 |
|
Arterial Puncture Closing Devices Compared With Standard Manual Compression After Cardiac Catheterization
Systematic Review and Meta-analysis
Maria Koreny, MD;
Eva Riedmüller, MD;
Mariam Nikfardjam, MD;
Peter Siostrzonek, MD;
Marcus Müllner, MD, MSc
JAMA. 2004;291:350-357.
Context Arterial puncture closing devices (APCDs) were developed to replace standard compression at the puncture site and to shorten bed rest following percutaneous coronary intervention.
Objective To assess the safety and efficacy of APCDs (Angioseal, Vasoseal, Duett, Perclose, Techstar, Prostar) compared with standard manual compression in patients undergoing coronary angiography or percutaneous vascular interventions.
Data Sources A systematic literature search of MEDLINE (1966-January 2003), EMBASE (1989-January 2003), PASCAL (1996-January 2003), BIOSIS (1990-January 2003), and CINHAL (1982-January 2003) databases and the Cochrane Central Register of Controlled Trials for relevant articles in any language.
Study Selection Included randomized controlled trials reporting vascular complications at the puncture site (hematoma, bleeding, arteriovenous fistula, pseudoaneurysm) and efficacy (time to hemostasis, time to ambulation, time to discharge from hospital).
Data Extraction Two reviewers abstracted the data independently and in duplicate. Disagreements were resolved by discussion among at least 3 reviewers. The most important criteria were adequacy of allocation concealment, whether the analysis was according to the intention-to-treat principle, and if person assessing the outcome was blinded to intervention group. Random-effects models were used to pool the data.
Data Synthesis Thirty trials met the selection criteria and included up to 4000 patients. When comparing any APCD with standard compression, the relative risk (RR) of groin hematoma was 1.14 (95% confidence interval [CI], 0.86-1.51; P = .35); bleeding, 1.48 (95% CI, 0.88-2.48; P = .14); developing an arteriovenous fistula, 0.83 (95% CI, 0.23-2.94; P = .77); and developing a pseudoaneurysm at the puncture site, 1.19 (95% CI, 0.75-1.88; P = .46). Time to hemostasis was shorter in the group with APCD compared with standard compression (mean difference, 17 minutes; range, 14-19 minutes), but there was a high degree of heterogeneity among studies. Only 2 studies explicitly reported allocation concealment, blinded outcome assessment, and intention-to-treat analysis. When limiting analyses to only trials that used explicit intention-to-treat approaches, APCDs were associated with a higher risk of hematoma (RR, 1.89; 95% CI, 1.13-3.15) and a higher risk of pseudoaneurysm (RR, 5.40; 95% CI, 1.21-24.5).
Conclusions Based on this meta-analysis of 30 randomized trials, many of poor methodological quality, there is only marginal evidence that APCDs are effective and there is reason for concern that these devices may increase the risk of hematoma and pseudoaneurysm.
Author Affiliations: Departments of Emergency Medicine (Drs Koreny, Riedmüller, and Müllner) and Internal Medicine 2, Division of Cardiology (Dr Nikfardjam), University of Vienna, Vienna General Hospital, Vienna, Austria; and Department of Internal Medicine, K. H. Barmherzige Schwestern, Linz, Austria (Dr Siostrzonek).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
A Randomized Comparison of a Novel Bioabsorbable Vascular Closure Device Versus Manual Compression in the Achievement of Hemostasis After Percutaneous Femoral Procedures: The ECLIPSE (Ensure's Vascular Closure Device Speeds Hemostasis Trial)
Wong et al.
J Am Coll Cardiol Intv 2009;2:785-793.
ABSTRACT
| FULL TEXT
Femoral Artery Closure After Cardiac Catheterization
Hamel
Crit Care Nurse 2009;29:39-46.
FULL TEXT
Association of the arterial access site at angioplasty with transfusion and mortality: the M.O.R.T.A.L study (Mortality benefit Of Reduced Transfusion after percutaneous coronary intervention via the Arm or Leg)
Chase et al.
Heart 2008;94:1019-1025.
ABSTRACT
| FULL TEXT
Complications Associated With the Arterial Puncture Closure Device--Angio-Seal
Kadner et al.
VASC ENDOVASCULAR SURG 2008;42:225-227.
ABSTRACT
Trends in Vascular Complications After Diagnostic Cardiac Catheterization and Percutaneous Coronary Intervention Via the Femoral Artery, 1998 to 2007
Applegate et al.
J Am Coll Cardiol Intv 2008;1:317-326.
ABSTRACT
| FULL TEXT
Closure devices for femoral punctures
Malik
Heart 2008;94:547-548.
FULL TEXT
Consensus document on antithrombotic therapy in the setting of electrophysiological procedures
Blanc et al.
Europace 2008;10:513-527.
FULL TEXT
Major Femoral Bleeding Complications After Percutaneous Coronary Intervention: Incidence, Predictors, and Impact on Long-Term Survival Among 17,901 Patients Treated at the Mayo Clinic From 1994 to 2005
Doyle et al.
J Am Coll Cardiol Intv 2008;1:202-209.
ABSTRACT
| FULL TEXT
Vascular Closure Devices: The Second Decade
Dauerman et al.
J Am Coll Cardiol 2007;50:1617-1626.
ABSTRACT
| FULL TEXT
Vascular Injury From an Arterial Closure Device
Lin et al.
J Ultrasound Med 2007;26:1441-1444.
FULL TEXT
Contemporary Management of Postcatheterization Pseudoaneurysms
Webber et al.
Circulation 2007;115:2666-2674.
FULL TEXT
The Case for Outpatient Coronary Intervention: Balancing Charges and Discharges
Resnic
Circulation 2007;115:2248-2250.
FULL TEXT
Randomized Trial Comparing Same-Day Discharge With Overnight Hospital Stay After Percutaneous Coronary Intervention: Results of the Elective PCI in Outpatient Study (EPOS)
Heyde et al.
Circulation 2007;115:2299-2306.
ABSTRACT
| FULL TEXT
Iatrogenic Limb Ischemia Caused by Angiography Closure Devices
Derham et al.
VASC ENDOVASCULAR SURG 2007;40:492-494.
ABSTRACT
Decreasing vascular complications after percutaneous coronary interventions: partnering to improve outcomes.
Lins et al.
Crit Care Nurse 2006;26:38-45.
FULL TEXT
Walk This Way: Early Ambulation After Cardiac Catheterization--Good for the Patient and the Health Care System
Chhatriwalla and Bhatt
Mayo Clin Proc. 2006;81:1535-1536.
FULL TEXT
Ambulation 1 Hour After Diagnostic Cardiac Catheterization: A Prospective Study of 1009 Procedures
Doyle et al.
Mayo Clin Proc. 2006;81:1537-1540.
ABSTRACT
| FULL TEXT
Prediction of iatrogenic pseudoaneurysm after percutaneous endovascular procedures.
Mlekusch et al.
Radiology 2006;240:597-602.
ABSTRACT
| FULL TEXT
Urgent Stenting of the M2 (Superior) Division of the Middle Cerebral Artery after Systemic Thrombolysis in Acute Stroke
Gupta et al.
Am. J. Neuroradiol. 2006;27:521-523.
ABSTRACT
| FULL TEXT
Part 14: First Aid
Circulation 2005;112:IV-196-IV-203.
FULL TEXT
Part 10: First Aid
Circulation 2005;112:III-115-III-125.
FULL TEXT
Efficacy and Safety of the Perclose Closer S Device After Neurointerventional Procedures: Prospective Study and Literature Review
Khaghany et al.
Am. J. Neuroradiol. 2005;26:1420-1424.
ABSTRACT
| FULL TEXT
What is the proper activated clotting time (ACT) at which to remove a femoral sheath after PCI? What are the best "protocols" for sheath removal?
Galli and Palatnik
Crit Care Nurse 2005;25:88-5.
FULL TEXT
Risk factors for the development of retroperitoneal hematoma after percutaneous coronary intervention in the era of glycoprotein IIb/IIIa inhibitors and vascular closure devices
Farouque et al.
J Am Coll Cardiol 2005;45:363-368.
ABSTRACT
| FULL TEXT
Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: A meta-analysis
Nikolsky et al.
J Am Coll Cardiol 2004;44:1200-1209.
ABSTRACT
| FULL TEXT
Arterial-Puncture Closing Devices vs. Manual Compression After Cath
Journal Watch Cardiology 2004;2004:4-4.
FULL TEXT
|
